2021
DOI: 10.1111/ced.14699
|View full text |Cite
|
Sign up to set email alerts
|

Natalizumab‐induced acquired perforating dermatosis

Abstract: Click https://wileyhealthlearning.com/#/online-courses/615dfa64-8585-45a0-9acd-78a11677651e for the corresponding questions to this CME article.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 3 publications
0
3
0
Order By: Relevance
“…1,2 Several later studies show that both collagen and elastin could penetrate the surface of RPC-like lesions. [3][4][5] There may be different results of PF, KD and RPC in the same patient depending on the sites, period, and layers of the biopsy. 3,6,7 This type of disease is therefore considered to be uniformly named acquired perforating dermatoses (APD).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…1,2 Several later studies show that both collagen and elastin could penetrate the surface of RPC-like lesions. [3][4][5] There may be different results of PF, KD and RPC in the same patient depending on the sites, period, and layers of the biopsy. 3,6,7 This type of disease is therefore considered to be uniformly named acquired perforating dermatoses (APD).…”
Section: Introductionmentioning
confidence: 99%
“…Based upon the nature of the eliminated material and the type of epidermal disorder, acquired perforating dermatoses traditionally tend to be divided into four subtypes: Kyrle's disease (KD), perforating folliculitis (PF), elastosis perforans serpiginosa (EPS), and reactive perforating collagenosis (RPC) 1,2 . Several later studies show that both collagen and elastin could penetrate the surface of RPC‐like lesions 3–5 . There may be different results of PF, KD and RPC in the same patient depending on the sites, period, and layers of the biopsy 3,6,7 .…”
Section: Introductionmentioning
confidence: 99%
“…1 Natalizumab and other biologics have also been implicated to cause APD. 2 Although still unknown, the pathogenesis of APD in patients with systemic disease is believed to consist of microangiopathy from endocrine disturbances, dermal deposition of compounds that remain after hemodialysis, or pruritus that results in cutaneous trauma which then leads to subsequent damage to the dermal-epidermal junction. 3 This damage is believed to facilitate keratinocyte interaction with modified or damaged connective tissue elements in a manner that results in their transepidermal elimination.…”
mentioning
confidence: 99%